On the fly News and insights, exclusive to thefly.com

BTAI

BioXcel Therapeutics

$45.70 /

-1.46 (-3.10%)

, ONEM

1Life Healthcare

$29.00 /

+0.06 (+0.21%)

09:56
10/30/20
10/30
09:56
10/30/20
09:56

Fly Intel: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. BioXcel Therapeutics (BTAI) initiated with a Buy at Goldman Sachs. 2. 1Life Healthcare (ONEM) initiated with an Outperform at Credit Suisse. 3. Durect (DRRX) initiated with a Buy at Chardan. 4. 9 Meters Biopharma (NMTR) initiated with a Buy at Maxim. 5. Aldeyra (ALDX) initiated with a Buy at Jefferies. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

BTAI

BioXcel Therapeutics

$45.70 /

-1.46 (-3.10%)

ONEM

1Life Healthcare

$29.00 /

+0.06 (+0.21%)

DRRX

Durect

$1.79 /

+0.025 (+1.42%)

NMTR

9 Meters Biopharma

$0.68 /

+0.0092 (+1.37%)

ALDX

Aldeyra

$6.60 /

+0.3 (+4.76%)

  • 02

    Nov

  • 05

    Nov

  • 09

    Nov

  • 10

    Nov

  • 13

    Nov

  • 31

    Jan

  • 20

    Feb

  • 25

    Jun

  • 29

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.